相关实验视频
Updated: Jun 23, 2026

00:09
Pooled CRISPR-Based Genetic Screens in Mammalian Cells
Published on: September 4, 2019
21.8K
通过CRISPR查,通过双层调节机制,确定PRMT1是关键的亲铁基因
Xin Zhang1, Yajun Duan2, Su Li2
1State Key Laboratory of Natural Medicines, Department of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, China; Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Cancer Research Center, Department of Pharmacology, Shenzhen University Medical School, Shenzhen 518055, China.
Cell reports
|August 23, 2024
概括
蛋白质氨酸甲基转移酶1 (PRMT1) 通过降低谷氨和抑制铁衰减抑制蛋白1 (FSP1) 来促进铁衰. 在小鼠中抑制PRMT1可以防止肝脏铁亡并改善存活率,这表明PRMT1是治疗标.
科学领域:
- 细胞死亡研究 细胞死亡研究
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 铁,一种依赖于铁的细胞死亡,在各种疾病中至关重要.
- 铁亡的调节者仍然不完全理解.
- 识别新型调节剂是治疗开发的关键.
研究的目的:
- 为了确定铁灭的新型调节剂.
- 阐明PRMT1影响铁亡的机制.
- 评估针对PRMT1.1的治疗潜力.
主要方法:
- 基因查CRISPR-Cas9以确定铁灭调节剂.
- 蛋白质与蛋白质相互作用和翻译后修改的分析.
- 在体内研究,使用小鼠肝损伤模型.
主要成果:
- 蛋白质氨酸甲基转移酶1 (PRMT1) 被确定为铁亡的促进物.
- PRMT1降低了溶解物载体家族7成员11 (SLC7A11) 的表达,降低了谷氨 (GSH) 水平.
- PRMT1通过氨酸二甲基化抑制铁灭抑制蛋白1 (FSP1) 的活性,降低CoQ10H2含量.
- 在小鼠中抑制PRMT1,保护小鼠免受肝脏铁亡,并改善生存率.
结论:
- PRMT1是通过多种机制促进铁亡的关键调节者.
- 向PRMT1提供了一种潜在的治疗策略,用于治疗与铁死相关的疾病.
- 抑制PRMT1证明了预防肝脏ferroptosis in vivo的有效性.
关键词:
ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA ADMA was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was that was was was was was was was was was was was was was was was was that was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was wasCP: 免疫学 免疫学CP:新陈代谢过程中的新陈代谢.FSP1SP1 在线播放在PRMT1中,在 SLC7A1111 中.急性肝损伤是什么?铁性化 (ferroptosis) 是一种
